XML 125 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 19,388 $ (2,474) $ 26,152 $ 10,136
Selling, general and administrative 49,035 12,439 69,469 22,028
Total operating expenses 68,423 9,965 95,621 32,164
Operating loss (68,423) (9,965) (95,621) (32,164)
Other income/(expense):        
Research and development tax credit 847 (1,934) 1,432 379
Loss on extinguishment of debt (3,653) 0 (3,653) 0
Interest income 3,140 3,402 6,518 6,079
Interest expense (1,757) (740) (3,343) (1,033)
Foreign exchange gain/(loss) 25 740 (194) 1,672
Total other (expense)/income, net (1,398) 1,468 760 7,097
Loss before income taxes (69,821) (8,497) (94,861) (25,067)
Income tax expense (1,014) (310) (1,768) (483)
Net loss $ (70,835) $ (8,807) $ (96,629) $ (25,550)
Profit/(loss) per share, basic (in dollars per share) $ (0.11) $ (0.01) $ (0.15) $ (0.04)
Profit/(loss) per share, diluted (in dollars per share) $ (0.11) $ (0.01) $ (0.15) $ (0.04)
Weighted-average shares outstanding, basic (in shares) 648,217,000 634,469,000 646,959,000 627,996,000
Weighted-average shares outstanding, diluted (in shares) 648,217,000 634,469,000 646,959,000 627,996,000